This article reviews the current status and controversies of the 3 commonly used antifibrinolytics-epsilon-aminocaproic acid, tranexamic acid and aprotinin-during liver transplantation. There is no general consensus on how, when or which antifibrinolytics should be used in liver transplantation. Alt
β¦ LIBER β¦
Antifibrinolytics and Orthotopic Liver Transplantation
β Scribed by R.P. Kufner
- Book ID
- 117235864
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 102 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antifibrinolytics in orthotopic liver tr
β
Victor W. Xia; Randolph H. Steadman
π
Article
π
2004
π
John Wiley and Sons
π
English
β 97 KB
Antifibrinolytics do not reduce transfus
β
Kufner, R
π
Article
π
1997
π
John Wiley and Sons
π
English
β 94 KB
Use of antifibrinolytics in orthotopic l
β
R.P Kufner
π
Article
π
2000
π
Elsevier Science
π
English
β 51 KB
Comparative study of antifibrinolytic dr
β
A Dalmau; A SabatΓ©; F Acosta; L Garcia-Huete; M Koo; M Reche; A Rafecas; J Figue
π
Article
π
1999
π
Elsevier Science
π
English
β 54 KB
Antifibrinolytics do not reduce transfus
β
Kufner, R P
π
Article
π
1997
π
Wiley (John Wiley & Sons)
π
English
β 97 KB
Hemorrhaging continues to be a significant problem in patients undergoing orthotopic liver transplantation (OLT). Massive transfusion has been associated with morbidity and mortality. In addition, the use of large amounts of blood products for OLT can place a huge demand on the blood banking system
Use of antifibrinolytics in liver transp
β
McMullan, V.; Thomson, E.; Beattie, C.
π
Article
π
2014
π
Oxford University Press
π
English
β 155 KB